# KCNC2

## Overview
The KCNC2 gene encodes the potassium voltage-gated channel subfamily C member 2, commonly referred to as the Kv3.2 channel. This protein is a transmembrane ion channel that plays a pivotal role in the regulation of neuronal excitability by facilitating the rapid repolarization of action potentials in neurons. Kv3.2 channels are predominantly expressed in the central nervous system, including key areas such as the hippocampus and frontal cortex, where they contribute to the high-frequency firing of fast-spiking neurons, particularly GABAergic interneurons (Wang2022Emerging; RUDY1999Contributions). The channel's structure is characterized by six transmembrane segments, with a voltage-sensing domain and a potassium-selective pore, which are essential for its function in maintaining neuronal firing rates and preventing hyperexcitability (Wang2022Emerging; Schwarz2021Heterozygous). Mutations in the KCNC2 gene have been implicated in various epilepsy syndromes, highlighting its clinical significance and potential as a therapeutic target (Seiffert2023KCNC2; Schwarz2021Heterozygous).

## Structure
The KCNC2 gene encodes the Kv3.2 potassium channel, a member of the Shaw-related voltage-gated potassium channel family. This protein is characterized by six transmembrane segments, with the fourth segment functioning as a voltage sensor. The extracellular loop between the fifth and sixth transmembrane domains acts as a selectivity filter for potassium ions (Wang2022Emerging; Schwarz2021Heterozygous). The primary structure of the KCNC2 protein includes a sequence of amino acids forming the channel, with specific residues like R405 and Val471 being highly conserved across species, indicating their functional importance (Vetri2020A; Wang2022Emerging).

The secondary structure involves the arrangement of these transmembrane segments into alpha helices, contributing to the formation of the ion-selective pore (Wang2022Emerging). The tertiary structure is affected by variants such as R405G, which disrupts hydrogen bonding and potentially alters the pore structure (Wang2022Emerging). The quaternary structure involves the tetramerization of the protein, facilitated by the cytoplasmic N-terminal T1 domain, which is crucial for the assembly of the functional channel (Schwarz2021Heterozygous). The C-terminal region is predicted to be mainly unstructured (Schwarz2021Heterozygous).

## Function
The KCNC2 gene encodes the Kv3.2 protein, a member of the voltage-gated potassium channel family, which plays a crucial role in neuronal excitability and function. Kv3.2 channels are primarily expressed in the central nervous system, particularly in regions such as the hippocampus, frontal cortex, and hypothalamus, and are found in both inhibitory and excitatory neurons (Wang2022Emerging). These channels are essential for maintaining high-frequency firing in fast-spiking neurons, such as GABAergic interneurons, by facilitating rapid repolarization of action potentials. This rapid repolarization minimizes Na+ channel inactivation and accelerates recovery, allowing neurons to fire at high frequencies without prolonged refractory periods (Lau2000Impaired; RUDY1999Contributions).

Kv3.2 channels activate at very depolarized potentials and deactivate quickly, which is critical for the fast-spiking properties of neurons involved in processes like synaptic transmission and modulation of excitation (Lau2000Impaired; RUDY1999Contributions). The absence of Kv3.2 impairs the fast-spiking ability of these neurons, leading to increased cortical excitability and susceptibility to seizures, highlighting its role in maintaining normal neuronal function and preventing hyperexcitability (Lau2000Impaired).

## Clinical Significance
Mutations in the KCNC2 gene, which encodes the potassium channel subunit Kv3.2, have been linked to a variety of epilepsy phenotypes. These include genetic generalized epilepsy (GGE), developmental and epileptic encephalopathy (DEE), early-onset absence epilepsy (EOAE), and epilepsy with focal seizures (FE) (Seiffert2023KCNC2; Schwarz2021Heterozygous). Specific variants such as p.Val471Leu, located in the S6 transmembrane domain, have been associated with severe DEE, characterized by symptoms like spastic tetraplegia and frequent seizures (Vetri2020A; Vetri2024Whole).

The KCNC2 variants can exhibit different functional impacts, such as gain-of-function or loss-of-function effects, which correlate with the severity of the epilepsy phenotype. For instance, gain-of-function mutations are often linked to more severe epilepsy forms, while loss-of-function mutations are associated with milder conditions (Schwarz2021Heterozygous). Some variants, like F382C, show mixed changes in channel kinetics, contributing to conditions such as myoclonic-atonic epilepsy (Seiffert2023KCNC2).

The KCNC2 gene's role in epilepsy underscores its importance in maintaining proper neuronal excitability and highlights its potential as a target for precision medicine approaches in treating epilepsy (Schwarz2021Heterozygous).

## Interactions



## References


[1. (Lau2000Impaired) David Lau, Eleazar Vega-Saenz de Miera, Diego Contreras, Ander Ozaita, Michael Harvey, Alan Chow, Jeffrey L. Noebels, Richard Paylor, James I. Morgan, Christopher S. Leonard, and Bernardo Rudy. Impaired fast-spiking, suppressed cortical inhibition, and increased susceptibility to seizures in mice lacking kv3.2 k+channel proteins. The Journal of Neuroscience, 20(24):9071–9085, December 2000. URL: http://dx.doi.org/10.1523/jneurosci.20-24-09071.2000, doi:10.1523/jneurosci.20-24-09071.2000. This article has 202 citations.](https://doi.org/10.1523/jneurosci.20-24-09071.2000)

2. (Schwarz2021Heterozygous) Heterozygous variants in KCNC2 cause a broad spectrum of epilepsy phenotypes associated with characteristic functional alterations. This article has 3 citations.

[3. (Vetri2024Whole) Luigi Vetri, Francesco Calì, Salvatore Saccone, Mirella Vinci, Natalia Valeria Chiavetta, Marco Carotenuto, Michele Roccella, Carola Costanza, and Maurizio Elia. Whole exome sequencing as a first-line molecular genetic test in developmental and epileptic encephalopathies. International Journal of Molecular Sciences, 25(2):1146, January 2024. URL: http://dx.doi.org/10.3390/ijms25021146, doi:10.3390/ijms25021146. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms25021146)

[4. (Wang2022Emerging) Sumei Wang, Yejing Yu, Xu Wang, Xiaolong Deng, Jiehui Ma, Zhisheng Liu, Weiyue Gu, and Dan Sun. Emerging evidence of genotype–phenotype associations of developmental and epileptic encephalopathy due to kcnc2 mutation: identification of novel r405g. Frontiers in Molecular Neuroscience, August 2022. URL: http://dx.doi.org/10.3389/fnmol.2022.950255, doi:10.3389/fnmol.2022.950255. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2022.950255)

[5. (Seiffert2023KCNC2) Simone Seiffert, Manuela Pendziwiat, Ulrike B. S. Hedrich, Ingo Helbig, Yvonne Weber, and Niklas Schwarz. Kcnc2 variants of uncertain significance are also associated to various forms of epilepsy. Frontiers in Neurology, June 2023. URL: http://dx.doi.org/10.3389/fneur.2023.1212079, doi:10.3389/fneur.2023.1212079. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fneur.2023.1212079)

[6. (RUDY1999Contributions) BERNARDO RUDY, ALAN CHOW, DAVID LAU, YIMY AMARILLO, ANDER OZAITA, MICHAEL SAGANICH, HERMAN MORENO, MARCELA S. NADAL, RICARDO HERNANDEZ‐PINEDA, ARTURO HERNANDEZ‐CRUZ, ALEV ERISIR, CHRISTOPHER LEONARD, and ELEAZAR VEGA‐SAENZ DE Miera. Contributions of kv3 channels to neuronal excitability. Annals of the New York Academy of Sciences, 868(1):304–343, April 1999. URL: http://dx.doi.org/10.1111/j.1749-6632.1999.tb11295.x, doi:10.1111/j.1749-6632.1999.tb11295.x. This article has 250 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/j.1749-6632.1999.tb11295.x)

[7. (Vetri2020A) Luigi Vetri, Francesco Calì, Mirella Vinci, Carmelo Amato, Michele Roccella, Tiziana Granata, Elena Freri, Roberta Solazzi, Valentino Romano, and Maurizio Elia. A de novo heterozygous mutation in kcnc2 gene implicated in severe developmental and epileptic encephalopathy. European Journal of Medical Genetics, 63(4):103848, April 2020. URL: http://dx.doi.org/10.1016/j.ejmg.2020.103848, doi:10.1016/j.ejmg.2020.103848. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ejmg.2020.103848)